This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings-outlook: Archive
Integra Resources Corp. (ITRG) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Integra Resources (ITRG) delivered earnings and revenue surprises of +55.17% and +2.89%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ITRGNegative Net Change TECKPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Draganfly Inc. (DPRO) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Draganfly (DPRO) delivered earnings and revenue surprises of -60.00% and -18.59%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
DPROPositive Net Change TXTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
M-tron Industries, Inc. (MPTI) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
M-tron Industries, Inc. (MPTI) delivered earnings and revenue surprises of +54.69% and +1.66%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
MPTIPositive Net Change URIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Worthington Enterprises (WOR) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Worthington Enterprises (WOR) delivered earnings and revenue surprises of +3.70% and +8.68%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
WORPositive Net Change WYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
MaxCyte, Inc. (MXCT) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
MaxCyte (MXCT) delivered earnings and revenue surprises of +25.00% and -17.98%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
MXCTNegative Net Change GILDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Intrusion Inc. (INTZ) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Intrusion (INTZ) delivered earnings and revenue surprises of -55.56% and -27.88%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
INTZNegative Net Change VRTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
KB Home (KBH) Q1 Earnings Meet Estimates
by Zacks Equity Research
KB Home (KBH) delivered earnings and revenue surprises of +0.27% and -1.98%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
KBHNegative Net Change TMHCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
ABSCI CORP (ABSI) delivered earnings and revenue surprises of -40.24% and -82.15%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ABSIPositive Net Change BRTXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AAR (AIR) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
AAR (AIR) delivered earnings and revenue surprises of +3.31% and +4.72%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
AIRPositive Net Change HXLPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
TELA Bio (TELA) delivered earnings and revenue surprises of +11.11% and -0.62%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
TELANegative Net Change RNXTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank